Dysregulated erythropoietin-producing hepatocellular receptor A2 (EphA2) is involved in tubal pregnancy via regulating cell adhesion of the Fallopian tube epithelial cells

被引:3
|
作者
Jiang, Huan [1 ]
Yang, Xiao-Yi [2 ]
Zhu, Wei-Jie [2 ]
机构
[1] Longgang Dist Maternal & Child Healthcare Hosp, Dept Reprod Endocrinol, 6 Ailong Rd, Shenzhen 518172, Peoples R China
[2] Jinan Univ, Coll Life Sci & Technol, Inst Reprod Immunol, 601 Huangpu Da Dao Xi, Guangzhou 510632, Guangdong, Peoples R China
来源
关键词
Receptor; EphA2; Cell adhesion; Fallopian tube; Pregnancy; Tubal; TYROSINE KINASE EPHA2; ECTOPIC PREGNANCY; MALIGNANT-CELLS; EXPRESSION; ACTIVATION; OVIDUCT; CANCER; DEPHOSPHORYLATION; SYSTEM; GROWTH;
D O I
10.1186/s12958-018-0403-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Tyrosine kinase receptor erythropoietin-producing hepatocellular receptor A2 (EphA2) is abundant in the endometrium and plays a role in the establishment of eutopic implantation. A similar molecular mechanism may exist between uterine implantation and tubal implantation, therefore EphA2 involvement in tubal pregnancy is suspected. Due to the limited availability of human Fallopian tube specimens, EphA2 expression in human Fallopian tube epithelium remains largely unknown. Methods: A total of 31 women with tubal pregnancy and 41 non-pregnant women with benign uterine diseases were enrolled in this study. Immunohistochemistry was used to investigate the expression pattern of EphA2 in the Fallopian tube epithelium of non-pregnant women (n = 29) and women with tubal pregnancy (n = 17). The changes of EphA2 and its activated form, phosphorylated-EphA2 (Pho-EphA2), in the Fallopian tube epithelium from non-pregnant women (n = 12) and women with tubal pregnancy (n = 14) were compared by quantitative RT-PCR and western blot assay. Results: EphA2 was expressed throughout the Fallopian tube epithelium, including the isthmus, the ampulla and the infundibulum. EphA2 concentration remained unchanged throughout the whole menstrual cycle, irrespective of menstrual phases and tubal regions. EphA2 mRNA in the Fallopian tube epithelium did not differ between normal women and women with tubal pregnancy (P> 0.05). With respect to the protein level, a significantly higher ratio of EphA2 over Pho-EphA2 was shown in women with tubal pregnancy (P < 0.05). Conclusions: EphA2 is widely expressed in human Fallopian tube epithelium in a temporospatial-independent manner. Dysregulated EphA2 and its phosphorylation-dependent regulatory mechanism may unexpectedly enhance the cell adhesion activity of the Fallopian tube epithelial cells, leading to a mis-contact between the Fallopian tube epithelium and the embryo.
引用
收藏
页数:9
相关论文
共 16 条
  • [1] Dysregulated erythropoietin-producing hepatocellular receptor A2 (EphA2) is involved in tubal pregnancy via regulating cell adhesion of the Fallopian tube epithelial cells
    Huan Jiang
    Xiao-Yi Yang
    Wei-Jie Zhu
    Reproductive Biology and Endocrinology, 16
  • [2] Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation
    Yang, Xiao-Yi
    Zhu, Wei-Jie
    Jiang, Huan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 361 (1-2) : 259 - 265
  • [3] Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation
    Xiao-Yi Yang
    Wei-Jie Zhu
    Huan Jiang
    Molecular and Cellular Biochemistry, 2012, 361 : 259 - 265
  • [4] New Diagnostic Biomarker-Soluble Erythropoietin-producing hepatocellular receptor A2 (EphA2) for colon cancer
    Ümit Haluk Iliklerden
    Tolga Kalayci
    Indian Journal of Surgery, 2023, 85 : 301 - 306
  • [5] New Diagnostic Biomarker-Soluble Erythropoietin-producing hepatocellular receptor A2 (EphA2) for colon cancer
    Iliklerden, Umit Haluk
    Kalayci, Tolga
    INDIAN JOURNAL OF SURGERY, 2023, 85 (02) : 301 - 306
  • [6] Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)
    Watabe, Tadashi
    Iwasawa, Takumi
    Kimura, Hiroyuki
    Shirakami, Yoshifumi
    Naka, Sadahiro
    Kaneda, Kazuko
    Kobayashi, Takanori
    Omokawa, Marina
    Yagi, Yusuke
    Tomiyama, Noriyuki
    Kato, Kazunori
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [7] 111In-labeled-anti-EphA2 antibody for SPECT imaging tracer targeting erythropoietin-producing hepatocellular receptor A2
    Kimura, Hiroyuki
    Sasaki, Minon
    Yamada, Takumu
    Iwasawa, Takumi
    Kato, Kazunori
    Yasui, Hiroyuki
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S253 - S254
  • [8] A Putative Single-Photon Emission CT Imaging Tracer for Erythropoietin-Producing Hepatocellular A2 Receptor
    Furukawa, Takenori
    Kimura, Hiroyuki
    Torimoto, Hanae
    Yagi, Yusuke
    Kawashima, Hidekazu
    Arimitsu, Kenji
    Yasui, Hiroyuki
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (08): : 1238 - 1244
  • [9] The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
    Shin, Jae Min
    Han, Moon Soo
    Park, Jae Hyung
    Lee, Seung Hyeok
    Kim, Tae Hoon
    Lee, Sang Hag
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [10] Activity of the erythropoietin-producing hepatocellular A2 receptor (EphA2) targeting Bicycle® Toxin Conjugate (BTCTM) BCY6033 in EGFR inhibitor resistant non-small lung cancer (NSCLC) patient derived xenografts
    Ngo, Kenneth
    Ivanova, Elena V.
    Teceno, Tyler J.
    Campbell, Carly
    Lahdenranta, Johanna
    Blakemore, Stephen J.
    Bennett, Gavin
    Janne, Pasi A.
    Paweletz, Cloud P.
    Gokhale, Prafulla C.
    CANCER RESEARCH, 2022, 82 (12)